Department Head: Professor Gunhild M. Mælandsmo, PhD

Department of Tumour Biology comprises four research groups:

• Translational Cancer Therapy, headed by Professor Kjersti Flatmark (MD, PhD)
• Computational Cancer Genomics and Melanoma Systems Biology, headed by Professor Eivind Hovig (PhD)
• Molecular Biology of Sarcomas, headed by Jørgen Wesche (PhD)
• Metastasis Biology and Experimental Therapeutics,, headed by Professor Gunhild M. Mælandsmo (PhD)

Kjersti Flatmark	Eivind Hovig	Jørgen Wesche	G.M. Mælandsmo

Vision: 

Our vision is to enhance the understanding of mechanisms involved in cancer progression and metastasis - and to utilize this knowledge to improve cancer treatment.

Strategy:
Department of Tumor Biology emphasizes translational research in order to enhance the understanding of mechanisms involved in cancer progression and metastasis. Two main pillars in our research program are cancer genomics and investigations on biological features causing metastatic disease.

Goal:
Our aim is to identify candidate biomarkers and therapeutic targets, followed by validation in preclinical models and clinical trials.

Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital HF - Radiumhospitalet, Montebello, Box 4953 - Nydalen - 0424 Oslo, Norway
Telephone: (047) 22 78 18 79 Fax: (047) 22 78 18 95